Archive for September, 2003

A dose of reality

A dose of reality “The FDA yesterday opened two days of hearings on the subject of consumer advertising, for the first time publicly presenting survey data that shows prescription advertising is generating widespread skepticism among doctors.”


Click here for reuse options!
Copyright 2003 Biotechblog

Naturally blonde, brunette…

Naturally blonde, brunette… “Designer ‘therapies’ could one day be helping to restore our hair to its former colour and texture”


Click here for reuse options!
Copyright 2003 Biotechblog

Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome

Venter Announces $500K Prize for Significant Advances Toward $1,000 Genome “Just before lunch today at the GSAC conference, Craig Venter stood before the crowd and announced a mouth-watering proposition: a $500,000 Genomic Technology Prize to be awarded by the J. Craig Venter Science Foundation to a person or organization that develops technology ‘to significantly advance’ […]


Click here for reuse options!
Copyright 2003 Biotechblog

The Odd Couple – CombinatoRx brings matchmaking to drug discovery and development

The Odd Couple – CombinatoRx brings matchmaking to drug discovery and development While almost everyone in the drug industry is looking for ways to speed new drugs to market, CombinatoRx has taken a particularly pragmatic approach: Rather than looking for new drugs, it is searching for novel combinations of existing drugs with synergistic effects.


Click here for reuse options!
Copyright 2003 Biotechblog

GlaxoSmithKline Reveals Ingenuity

GlaxoSmithKline Reveals Ingenuity In a further validation of Big Pharma�s acceptance of systems biology, GlaxoSmithKline has licensed part of the Ingenuity Pathways Knowledge Base to facilitate genome-wide computational analysis of biological systems underlying disease.


Click here for reuse options!
Copyright 2003 Biotechblog

The Best in Drugs and Biotech

The Best in Drugs and Biotech: “S&P’s Herman Saftlas and Frank DiLorenzo share some favorites in these resurgent sectors, including Barr Pharmaceuticals and MedImmune “


Click here for reuse options!
Copyright 2003 Biotechblog

What VCs Don't Tell You

What VCs Don’t Tell You: “To secure funding, an entrepreneur needs to appreciate the goals and strategies at work on the other side the table. Here’s a guide “


Click here for reuse options!
Copyright 2003 Biotechblog

What VCs Don’t Tell You

What VCs Don’t Tell You: “To secure funding, an entrepreneur needs to appreciate the goals and strategies at work on the other side the table. Here’s a guide “


Click here for reuse options!
Copyright 2003 Biotechblog

Building a Better R&D Mousetrap

Building a Better R&D Mousetrap: “By posting their scientific conundrums online, companies like Eli Lilly and Procter & Gamble have discovered a rich new source of brainpower.”


Click here for reuse options!
Copyright 2003 Biotechblog

Building a Better R&D Mousetrap

Building a Better R&D Mousetrap: “By posting their scientific conundrums online, companies like Eli Lilly and Procter & Gamble have discovered a rich new source of brainpower.”


Click here for reuse options!
Copyright 2003 Biotechblog

%d bloggers like this: